Skip to content

Clinical trials

Adenocarcinoma of Lung trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20133
20151
20171
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
European Organisation for Research and Treatment of Cancer - EORTC2
AIO-Studien-gGmbH1
AstraZeneca1
Bayer1
Morphotek1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung11
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms7
Neoplasm Metastasis2
Adenocarcinoma, Bronchiolo-Alveolar1
Endometrial Neoplasms1
Head and Neck Neoplasms1
Melanoma1
Neoplasms1
Ovarian Neoplasms1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.